PharmiWeb.com - Global Pharma News & Resources
14-Jun-2019

Xerostomia Therapeutics Market 2019 Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024

Market Research Engine has published a new report titled asXerostomia Therapeutics Market Size, By Type (Over-the-Counter, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, Market Analysis Report, Forecast 2018-2024.”

Report scope:

Global xerostomia therapeutics market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global xerostomia therapeutics market share. Major industry players with significant revenue share include Synedgen, Parnell Pharmaceuticals Inc, GlaxoSmithKline PLC, Lupin, Church & Dwight Co. Inc, Acacia Pharma, OraCoat, Hikma, Parnell Pharmaceuticals, and Pfizer Inc.

Browse Full Report: https://www.marketresearchengine.com/xerostomia-therapeutics-market

Global xerostomia therapeutics market is segregated on the basis of product as, salivary stimulants, salivary substitutes, and dentifrices. Based on type, the global xerostomia therapeutics market is segmented as over-the-counter and prescription.

Global xerostomia therapeutics market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The xerostomia therapeutics market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

The easy availability of varied product portfolio is projected to fuel xerostomia therapeutics market share in several countries during the forecast period. Moreover, the presence of numerous players in the market is restraining the future revenue generation opportunities for the companies. The lack of awareness in several merging countries may hamper market growth over the projected time frame.

Rising instances of deadly diseases such as HIV, mouth cancer, diabetes, Alzheimer’s and other diseases propelling demand for effective xerostomia therapeutics across the globe. Increasing usage of radiotherapy and chemotherapy for effective cancer treatment majorly causes dry mouth or xerostomia to the patients. The radiation therapy affects the functioning of the salivary that last up few months after the treatment.

Competitive Rivalry

Synedgen, Parnell Pharmaceuticals Inc, GlaxoSmithKline PLC, Lupin, Church & Dwight Co. Inc, Acacia Pharma, OraCoat, Hikma, Parnell Pharmaceuticals, and Pfizer Inc are among the major players in the global xerostomia therapeutics market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Xerostomia Therapeutics Market has been segmented as below:

Xerostomia Therapeutics Market, By Type

  • Over-the-Counter (OTC)
  • Prescription

Xerostomia Therapeutics Market Research, By Product

  • Salivary Stimulants
  • Salivary Substitutes
  • Dentifrices

Xerostomia Therapeutics Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • Global xerostomia therapeutics market sizes from 2015 to 2024, along with CAGR for 2018-2024.
  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global xerostomia therapeutics market trends, covering comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the xerostomia therapeutics market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
  • Comprehensive company profiles of the key industry players

Reasons to Buy this Report:

  • Gain detailed insights on the xerostomia therapeutics industry trends
  • Find complete analysis on the market status
  • Identify the xerostomia therapeutics market opportunities and growth segments
  • Analyse competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Request Sample Report from here: https://www.marketresearchengine.com/xerostomia-therapeutics-market

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Driver 1
            4.2.2.    Driver 2
            4.2.3.    Driver 3
        4.3.    Restraints
            4.3.1.    Restraint 1
            4.3.2.    Restraint 2
        4.4.    Opportunities
            4.4.1.    Opportunity 1
            4.4.2.    Opportunity 2
        4.5.    Challenges
            4.5.1.    Challenge 1
            4.5.2.    Challenge 2
  5.  Xerostomia Therapeutics Market, By Type
  6.  Xerostomia Therapeutics Market, By Product
  7.  Competitive Landscape
  8.  Company Profile
     8.1.    Synedgen
            8.1.1.    Company Overview
            8.1.2.    Product/Service Landscape
            8.1.3.    Financial Overview
            8.1.4.    Recent Developments
        8.2.    Parnell Pharmaceuticals Inc
            8.2.1.    Company Overview
            8.2.2.    Product/Service Landscape
            8.2.3.    Financial Overview
            8.2.4.    Recent Developments
        8.3.    GlaxoSmithKline PLC
            8.3.1.    Company Overview
            8.3.2.    Product/Service Landscape
            8.3.3.    Financial Overview
            8.3.4.    Recent Developments
        8.4.    Lupin
            8.4.1.    Company Overview
            8.4.2.    Product/Service Landscape
            8.4.3.    Financial Overview
            8.4.4.    Recent Developments
        8.5.    Church & Dwight Co. Inc
            8.5.1.    Company Overview
            8.5.2.    Product/Service Landscape
            8.5.3.    Financial Overview
            8.5.4.    Recent Developments
        8.6.    Acacia Pharma
            8.6.1.    Company Overview
            8.6.2.    Product/Service Landscape
            8.6.3.    Financial Overview
            8.6.4.    Recent Developments
        8.7.    OraCoat
            8.7.1.    Company Overview
            8.7.2.    Product/Service Landscape
            8.7.3.    Financial Overview
            8.7.4.    Recent Developments
        8.8.    Hikma
            8.8.1.    Company Overview
            8.8.2.    Product/Service Landscape
            8.8.3.    Financial Overview
            8.8.4.    Recent Developments
        8.9.    Parnell Pharmaceuticals
            8.9.1.    Company Overview
            8.9.2.    Product/Service Landscape
            8.9.3.    Financial Overview
            8.9.4.    Recent Developments
        8.10.    Pfizer
            8.10.1.    Company Overview
            8.10.2.    Product/Service Landscape
            8.10.3.    Financial Overview
            8.10.4.    Recent Developments

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Related Links

Last Updated: 18-Jun-2019